Free Trial

Short Interest in Arkema SA (OTCMKTS:ARKAY) Grows By 86.2%

Arkema logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest in Arkema rose by 86.2% to 108 shares as of March 13, but this remains negligible—about 0.0% of shares sold short with a days-to-cover of 0.0 due to average daily volume.
  • Analyst sentiment is mixed with an average rating of Reduce (2 Buys, 3 Holds, 3 Sells); recent notable moves include Goldman Sachs upgrading to Buy, Kepler cutting to Hold, and Zacks downgrading to Strong Sell.
  • The stock trades near $63.69 with a market capitalization of $4.84 billion and a P/E of 73.21, indicating a relatively high valuation versus earnings.
  • MarketBeat previews the top five stocks to own by May 1st.

Arkema SA (OTCMKTS:ARKAY - Get Free Report) was the recipient of a significant growth in short interest in March. As of March 13th, there was short interest totaling 108 shares, a growth of 86.2% from the February 26th total of 58 shares. Approximately 0.0% of the company's stock are sold short. Based on an average daily volume of 6,988 shares, the days-to-cover ratio is presently 0.0 days.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Kepler Capital Markets cut shares of Arkema from a "strong-buy" rating to a "hold" rating in a report on Friday, February 27th. The Goldman Sachs Group upgraded shares of Arkema from a "hold" rating to a "buy" rating in a report on Tuesday, February 10th. Finally, Zacks Research downgraded shares of Arkema from a "hold" rating to a "strong sell" rating in a research report on Tuesday, January 6th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Reduce".

Read Our Latest Research Report on ARKAY

Arkema Stock Up 1.6%

ARKAY opened at $63.69 on Thursday. Arkema has a one year low of $56.28 and a one year high of $80.87. The company has a debt-to-equity ratio of 0.54, a quick ratio of 2.26 and a current ratio of 2.13. The stock has a market capitalization of $4.84 billion, a P/E ratio of 73.21, a price-to-earnings-growth ratio of 1.54 and a beta of 0.87. The business's 50-day simple moving average is $65.73 and its 200-day simple moving average is $62.94.

Arkema Company Profile

(Get Free Report)

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total's chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema's operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arkema Right Now?

Before you consider Arkema, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.

While Arkema currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines